Loading...
XNYS
JNJ
Market cap616bUSD
Jul 22, Last price  
255.63USD
1D
2.00%
1Q
10.83%
Jan 2017
121.88%
Name

Johnson & Johnson

Chart & performance

D1W1MN
XNYS:JNJ chart
P/E
22.96
P/S
6.53
EPS
11.13
Div yield, %
2.01%
Shrs. gr., 5y
-1.88%
Rev. gr., 5y
2.67%
Revenues
94.19b
+6.05%
67,224,000,00071,312,000,00071,312,000,00074,331,000,00074,331,000,00070,074,000,00070,074,000,00071,890,000,00071,890,000,00076,450,000,00081,581,000,00081,581,000,00082,059,000,00082,059,000,00082,584,000,00078,740,000,00079,990,000,00085,159,000,00088,821,000,00094,193,000,000
Net income
26.80b
+90.56%
10,853,000,00013,831,000,00013,831,000,00016,323,000,00016,323,000,00015,409,000,00015,409,000,00016,540,000,00016,540,000,0001,300,000,00015,297,000,00015,297,000,00015,119,000,00015,119,000,00014,714,000,00020,878,000,00017,941,000,00035,153,000,00014,066,000,00026,804,000,000
CFO
24.53b
+1.09%
15,396,000,00017,414,000,00017,414,000,00018,471,000,00018,471,000,00019,279,000,00019,279,000,00018,767,000,00018,767,000,00021,056,000,00022,201,000,00022,201,000,00023,416,000,00023,416,000,00023,536,000,00023,410,000,00021,194,000,00022,791,000,00024,266,000,00024,530,000,000
Dividend
Aug 25, 20261.34 USD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Johnson & Johnson functions as a global healthcare enterprise, involved in the research, development, manufacturing, and commercialization of a wide spectrum of health-related products. Its activities are organized across three principal divisions: Consumer Health, Pharmaceutical, and Medical Devices. The Consumer Health segment provides an extensive range of goods, encompassing baby care items under brands like JOHNSON'S and AVEENO Baby, oral hygiene products such as LISTERINE, and skin/beauty solutions from AVEENO, NEUTROGENA, and OGX. It also offers over-the-counter medications for various ailments, including pain relief (TYLENOL, MOTRIN IB), cold, flu, and allergy symptoms (SUDAFED, BENADRYL, ZYRTEC), smoking cessation aids (NICORETTE), and acid reflux treatments (PEPCID). Additionally, this division includes women's health products like STAYFREE and o.b., wound care essentials such as BAND-AID adhesive bandages, and NEOSPORIN for first aid. The Pharmaceutical segment is dedicated to developing therapies within significant therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and cardiovascular and metabolic disorders. The Medical Devices segment delivers sophisticated solutions for cardiovascular conditions, including electrophysiology and neurovascular care for strokes. It also provides orthopaedic products supporting hips, knees, trauma, spine, and sports-related needs, alongside advanced and general surgical solutions focusing on breast aesthetics and ear, nose, and throat procedures. Furthermore, this segment offers ophthalmic products, notably ACUVUE brand disposable contact lenses and technologies for cataract and laser refractive surgery. The company distributes its products through diverse channels, reaching the general public via retail outlets and distributors, and directly supplying wholesalers, hospitals, and healthcare professionals for prescription-based use. Johnson & Johnson was established in 1886 and maintains its headquarters in New Brunswick, New Jersey.
IPO date
Sep 25, 1944
Employees
152,700
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122023‑002022‑002021‑002019‑122019‑122018‑122018‑122017‑122017‑002016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT